Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...

Human metapneumovirus (HMPV) is a commonly found virus that can cause respiratory illness. Although it typically has no symptoms in healthy people, it can cause serious sickness in older adults, those ...

Five years after the first cases of COVID-19, reports of hMPV, an obscure respiratory virus in China may understandably raise ...

Analysis - Five years on from the first news of Covid-19, recent reports of an obscure respiratory virus in China may ...

Last summer, scientists at the University of Oxford launched a clinical trial of a combined RSV and hMPV vaccine in partnership with Moderna, and Andrew Pollard, a professor of infection and ...

Most children have had HMPV by the time they reach the age of ... There’s currently no cure or vaccine for the disease, though Moderna, the maker of a COVID-19 vaccine, is working to produce ...

According to the NAID, Moderna, the manufacturer of the Covid-19 vaccine, has just ended an early trial of an mRNA vaccine against HMPV and parainfluenza. According to respiratory virus ...